PMC:7358770 / 26225-26426 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"885","span":{"begin":7,"end":10},"obj":"Species"},{"id":"886","span":{"begin":170,"end":173},"obj":"Species"},{"id":"895","span":{"begin":129,"end":132},"obj":"Chemical"},{"id":"896","span":{"begin":87,"end":108},"obj":"Disease"}],"attributes":[{"id":"A885","pred":"tao:has_database_id","subj":"885","obj":"Tax:10407"},{"id":"A886","pred":"tao:has_database_id","subj":"886","obj":"Tax:11120"},{"id":"A896","pred":"tao:has_database_id","subj":"896","obj":"MESH:D006509"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ect on HBV replication in vivo, which can be used as a supplementary modality to treat hepatitis B infection [103]. Furthermore, APS can inhibit the replication of avian IBV in vitro in a dose-dependen"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T101","span":{"begin":87,"end":108},"obj":"Disease"},{"id":"T102","span":{"begin":87,"end":96},"obj":"Disease"},{"id":"T103","span":{"begin":99,"end":108},"obj":"Disease"},{"id":"T104","span":{"begin":129,"end":132},"obj":"Disease"}],"attributes":[{"id":"A101","pred":"mondo_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/MONDO_0005344"},{"id":"A102","pred":"mondo_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A103","pred":"mondo_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A104","pred":"mondo_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/MONDO_0017278"}],"text":"ect on HBV replication in vivo, which can be used as a supplementary modality to treat hepatitis B infection [103]. Furthermore, APS can inhibit the replication of avian IBV in vitro in a dose-dependen"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T284","span":{"begin":53,"end":54},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T285","span":{"begin":97,"end":98},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T286","span":{"begin":186,"end":187},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ect on HBV replication in vivo, which can be used as a supplementary modality to treat hepatitis B infection [103]. Furthermore, APS can inhibit the replication of avian IBV in vitro in a dose-dependen"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T401","span":{"begin":129,"end":132},"obj":"Chemical"}],"attributes":[{"id":"A401","pred":"chebi_id","subj":"T401","obj":"http://purl.obolibrary.org/obo/CHEBI_17709"}],"text":"ect on HBV replication in vivo, which can be used as a supplementary modality to treat hepatitis B infection [103]. Furthermore, APS can inhibit the replication of avian IBV in vitro in a dose-dependen"}

{"project":"2_test","denotations":[{"id":"32679328-19960563-48281318","span":{"begin":110,"end":113},"obj":"19960563"},{"id":"T49528","span":{"begin":110,"end":113},"obj":"19960563"}],"text":"ect on HBV replication in vivo, which can be used as a supplementary modality to treat hepatitis B infection [103]. Furthermore, APS can inhibit the replication of avian IBV in vitro in a dose-dependen"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T11","span":{"begin":87,"end":96},"obj":"Phenotype"}],"attributes":[{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"ect on HBV replication in vivo, which can be used as a supplementary modality to treat hepatitis B infection [103]. Furthermore, APS can inhibit the replication of avian IBV in vitro in a dose-dependen"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T738","span":{"begin":7,"end":10},"obj":"NCBITaxon:10376"},{"id":"T739","span":{"begin":11,"end":22},"obj":"GO:0006260"},{"id":"T740","span":{"begin":129,"end":132},"obj":"PR:000003015"},{"id":"T741","span":{"begin":149,"end":160},"obj":"GO:0006260"},{"id":"T742","span":{"begin":164,"end":169},"obj":"NCBITaxon:8782"},{"id":"T743","span":{"begin":170,"end":173},"obj":"NCBITaxon:10376"},{"id":"T32991","span":{"begin":25,"end":28},"obj":"PR:F4KFT7"},{"id":"T74527","span":{"begin":36,"end":41},"obj":"UBERON:0002405;GO:0006955"},{"id":"T98837","span":{"begin":42,"end":51},"obj":"GO:0006955"},{"id":"T50839","span":{"begin":75,"end":85},"obj":"UBERON:0001004"},{"id":"T99890","span":{"begin":86,"end":95},"obj":"NCBITaxon:12814"},{"id":"T31576","span":{"begin":96,"end":101},"obj":"NCBITaxon:10239"},{"id":"T74467","span":{"begin":103,"end":106},"obj":"NCBITaxon:11886"},{"id":"T65959","span":{"begin":134,"end":138},"obj":"UBERON:0002048"},{"id":"T40151","span":{"begin":157,"end":161},"obj":"NCBITaxon:10088"},{"id":"T40664","span":{"begin":182,"end":193},"obj":"CHEBI:3435;CHEBI:3435"}],"text":"ect on HBV replication in vivo, which can be used as a supplementary modality to treat hepatitis B infection [103]. Furthermore, APS can inhibit the replication of avian IBV in vitro in a dose-dependen"}

{"project":"MyTest","denotations":[{"id":"885","span":{"begin":7,"end":10},"obj":"Species"},{"id":"886","span":{"begin":170,"end":173},"obj":"Species"},{"id":"895","span":{"begin":129,"end":132},"obj":"Chemical"},{"id":"896","span":{"begin":87,"end":108},"obj":"Disease"}],"attributes":[{"id":"A885","pred":"tao:has_database_id","subj":"885","obj":"Tax:10407"},{"id":"A886","pred":"tao:has_database_id","subj":"886","obj":"Tax:11120"},{"id":"A896","pred":"tao:has_database_id","subj":"896","obj":"MESH:D006509"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"ect on HBV replication in vivo, which can be used as a supplementary modality to treat hepatitis B infection [103]. Furthermore, APS can inhibit the replication of avian IBV in vitro in a dose-dependen"}